Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study. [PDF]
Rizk DV +11 more
europepmc +1 more source
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. [PDF]
Boussier J +16 more
europepmc +1 more source
IntroductionEpidermolysis Bullosa Acquisita (EBA) is an autoimmune blistering dermatosis characterized by autoantibodies (AAbs) against type VII collagen (COL7) located at the dermal epidermal junction (DEJ).
Björn Laffer +7 more
doaj +1 more source
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial. [PDF]
Bomback AS +7 more
europepmc +1 more source
Activation of the Alternative Pathway of Guinea Pig Complement by Sendai Virus‐Treated Cells [PDF]
Noriko Okada +2 more
openalex +1 more source
Complement Pathway Associated Glomerulopathies [PDF]
The complement system causes kidney injury in a variety of different diseases, and clinical evaluation of the complement system is an important part of the diagnostic workup of patients with glomerulonephritis.
Yasar Caliskan
doaj
The Capacity of Lymphoblastoid Cells to Activate the Alternative Complement Pathway Is Correlated with their Transformation by Epstein-Barr Virus [PDF]
I. McConnell +3 more
openalex +1 more source
Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy. [PDF]
Liu M +6 more
europepmc +1 more source
Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli [PDF]
P Leist-Welsh, A. B. Bjornson
openalex +1 more source
Complement Activation in Semisolid Media: Insolubilization of Alternative Pathway Convertases in Agar Gels with C3 Nephritic Factor-Containing Sera [PDF]
Mohammed A. Arnaout +3 more
openalex +1 more source

